Johnson & Johnson
NYSE: JNJ
$164.16
-$0.66 (-0.4%)
Closing Price on September 20, 2024
JNJ Articles
For the S&P 500 index to move toward a new record, the prices of some of the largest components will need to make most of the momentum.
Published:
Last Updated:
For the most part, Jefferies maintained its list of top companies in the health care sector, but it also made a couple additions and updated its price target information.
Published:
Last Updated:
Monday's top analyst upgrades, downgrades and initiations Include Equinix, HCA, Johnson & Johnson, Performance Sports, Tesla and Yandex.
Published:
Last Updated:
With investors looking for safety and dividends for total return, the big pharmaceutical stocks are just the ticket, and these four are outstanding.
Published:
Last Updated:
It is time to take a look at the 2016 stock buyback kings, those companies that will spend the most buying back their common stock this year alone.
Published:
Last Updated:
February 5, 2016: Markets opened lower on Friday following a lower-than-expected report on nonfarm payrolls. There appears to be some concern that investors are worried about the impact of the...
Published:
Last Updated:
Johnson & Johnson reported its fourth-quarter financial results before the markets opened on Tuesday.
Published:
Last Updated:
Johnson & Johnson is set to release its fourth-quarter financial results before the markets open Tuesday.
Published:
Last Updated:
24/7 Wall St. has put together a preview of some of the Dow Jones Industrial Average companies (and others) that are reporting their quarterly results this week.
Published:
Last Updated:
Investors need to keep in mind that the downside target for the Dow Jones Industrial Average will sink lower if the market keeps drifting south.
Published:
Last Updated:
Johnson & Johnson is looking to save some money over the next few years and as a result it is taking action by restructuring its Medical Devices businesses.
Published:
Last Updated:
24/7 Wall Street has evaluated three major Dow components in the pharmaceutical industry and presented the bullish and bearish case for each in 2016.
Published:
Last Updated:
ThinkstockIn the second quarter of this year, U.S. corporate profits totalled $1.8 trillion after taxes. Massive corporate profit is not limited to the United States, although many of the world’s...
Published:
Last Updated:
ThinkstockJanssen Biotech announced that the U.S. Food and Drug Administration (FDA) approved Yondelis (trabectedin) for the treatment of patients with unresectable or metastatic liposarcoma (LPS) or...
Published:
Last Updated:
ThinkstockOctober 15, 2015: Markets opened higher on Thursday following a strong showing for stocks in both Asia and Europe. Biotech stocks continue to get new life, helping overcome some softness in...
Published:
Last Updated: